UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

The journal of clinical endocrinology and metabolism, 2011-02, Vol.96 (2), p.273-288

2011

Volltextzugriff (PDF)

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

The journal of clinical endocrinology and metabolism, 2013-03, Vol.98 (3), p.980-988

2013

Volltextzugriff (PDF)

IGF-I, GH, and Sex Steroid Effects in Normal Mammary Gland Development

Journal of mammary gland biology and neoplasia, 2008-12, Vol.13 (4), p.353-360

2008

Volltextzugriff (PDF)

Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency

The journal of clinical endocrinology and metabolism, 2002-05, Vol.87 (5), p.2067-2079

2002

Volltextzugriff (PDF)

The Pivotal Role of Insulin-Like Growth Factor I in Normal Mammary Development

Endocrinology and metabolism clinics of North America, 2011-09, Vol.40 (3), p.461-471

2011

Volltextzugriff (PDF)

Variability and Reliability of single Serum IGF-I Measurements: Impact on Determining Predictability of Risk Ratios in Disease Development

The journal of clinical endocrinology and metabolism, 2004-05, Vol.89 (5), p.2271-2274

2004

Volltextzugriff (PDF)

Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions

Endocrine reviews, 2009-02, Vol.30 (1), p.51-74

2009

Volltextzugriff (PDF)

Acromegaly: Assessing the Disorder and Navigating the Therapeutic Options for Treatment

Endocrine practice, 2014-10, Vol.20, p.7-17

2014

Volltextzugriff (PDF)

Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study

Clinical endocrinology (Oxford), 2008-01, Vol.68 (1), p.66-71

2008

Volltextzugriff (PDF)

Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials

Pituitary, 2015-06, Vol.18 (3), p.297-305

2015

Volltextzugriff (PDF)

Alternative approach to insulin-like growth factor-1 inhibition for treatment of breast cancer

Journal of clinical oncology, 2012-04, Vol.30 (12), p.1395-1396

2012

Volltextzugriff (PDF)

Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia

Pituitary, 2011-03, Vol.14 (1), p.44-52

2011

Volltextzugriff (PDF)

Growth Hormone Should Be Used Only for Approved Indications

The journal of clinical endocrinology and metabolism, 2014-02, Vol.99 (2), p.409-411

2014

Volltextzugriff (PDF)

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial

Breast cancer research : BCR, 2014-11, Vol.16 (6), p.463, Article 463

2014

Volltextzugriff (PDF)

Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action

Endocrinology (Philadelphia), 2005-03, Vol.146 (3), p.1170-1178

2005

Volltextzugriff (PDF)

Moderate Doses of hGH (0.64 mg/d) Improve Lipids But Not Cardiovascular Function in GH-Deficient Adults with Normal Baseline Cardiac Function

The journal of clinical endocrinology and metabolism, 2011-01, Vol.96 (1), p.122-132

2011

Volltextzugriff (PDF)

Insulin-Like Growth Factor (IGF)-I Controls Prostate Fibromuscular Development: IGF-I Inhibition Prevents Both Fibromuscular and Glandular Development in Eugonadal Mice

Endocrinology (Philadelphia), 2007-03, Vol.148 (3), p.1080-1088

2007

Volltextzugriff (PDF)

Role of IGF-I in normal mammary development

Breast cancer research and treatment, 1998-02, Vol.47 (3), p.201-208

Kleinberg, D L

1998

Volltextzugriff (PDF)

SOM230 Inhibits Insulin-Like Growth Factor-I Action in Mammary Gland Development by Pituitary Independent Mechanism: Mediated through Somatostatin Subtype Receptor 3?

Molecular endocrinology (Baltimore, Md.), 2006-02, Vol.20 (2), p.426-436

2006

Volltextzugriff (PDF)

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly

Endocrine practice, 2004-05, Vol.10 (3), p.213-225

2004

Volltextzugriff (PDF)

Evidence That the Mammary Fat Pad Mediates the Action of Growth Hormone in Mammary Gland Development

Endocrinology (Philadelphia), 1998-02, Vol.139 (2), p.659-662

1998

Volltextzugriff (PDF)

Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development1

Endocrinology (Philadelphia), 1999-11, Vol.140 (11), p.5075-5081

1999

Volltextzugriff (PDF)

GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90

Clinical endocrinology (Oxford), 2006-08, Vol.65 (2), p.169-177

2006

Volltextzugriff (PDF)

Early mammary development: growth hormone and IGF-1

Journal of mammary gland biology and neoplasia, 1997-01, Vol.2 (1), p.49-57

Kleinberg, D L

1997

Volltextzugriff (PDF)

Primary therapy for acromegaly with somatostatin analogs and a discussion of novel peptide analogs

Reviews in endocrine & metabolic disorders, 2005-01, Vol.6 (1), p.29-37

Kleinberg, David L

2005

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(125)
Mit Volltextzugriff
(127)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(86)
Humans
(74)
Life Sciences & Biomedicine
(74)
Female
(54)
Endocrinology & Metabolism
(41)
Biological And Medical Sciences
(38)
Male
(37)
Medical Sciences
(32)
Adult
(31)
Animals
(29)
Computer Science
(28)
Middle Aged
(28)
Informatique
(23)
Congresses
(21)
Aged
(20)
Fundamental And Applied Biological Sciences. Psychology
(20)
Informatika
(20)
Kongress
(17)
Vertebrates: Endocrinology
(15)
Artificial Intelligence
(14)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients

IGF-I, GH, and Sex Steroid Effects in Normal Mammary Gland Development

Sensitivity and Specificity of Six Tests for the Diagnosis of Adult GH Deficiency

The Pivotal Role of Insulin-Like Growth Factor I in Normal Mammary Development

Variability and Reliability of single Serum IGF-I Measurements: Impact on Determining Predictability of Risk Ratios in Disease Development

Growth Hormone and Insulin-Like Growth Factor-I in the Transition from Normal Mammary Development to Preneoplastic Mammary Lesions

Acromegaly: Assessing the Disorder and Navigating the Therapeutic Options for Treatment

Pregnancy outcomes following cabergoline treatment: extended results from a 12-year observational study

Effects of low dose versus high dose human growth hormone on body composition and lipids in adults with GH deficiency: a meta-analysis of placebo-controlled randomized trials

Alternative approach to insulin-like growth factor-1 inhibition for treatment of breast cancer

Pasireotide, an IGF-I action inhibitor, prevents growth hormone and estradiol-induced mammary hyperplasia

Growth Hormone Should Be Used Only for Approved Indications

Insulin-like growth factor-I inhibition with pasireotide decreases cell proliferation and increases apoptosis in pre-malignant lesions of the breast: a phase 1 proof of principle trial

Progesterone Stimulates Mammary Gland Ductal Morphogenesis by Synergizing with and Enhancing Insulin-Like Growth Factor-I Action

Moderate Doses of hGH (0.64 mg/d) Improve Lipids But Not Cardiovascular Function in GH-Deficient Adults with Normal Baseline Cardiac Function

Insulin-Like Growth Factor (IGF)-I Controls Prostate Fibromuscular Development: IGF-I Inhibition Prevents Both Fibromuscular and Glandular Development in Eugonadal Mice

Role of IGF-I in normal mammary development

SOM230 Inhibits Insulin-Like Growth Factor-I Action in Mammary Gland Development by Pituitary Independent Mechanism: Mediated through Somatostatin Subtype Receptor 3?

American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for the Diagnosis and Treatment of Acromegaly

Evidence That the Mammary Fat Pad Mediates the Action of Growth Hormone in Mammary Gland Development

Insulin-Like Growth Factor I Is Essential for Terminal End Bud Formation and Ductal Morphogenesis during Mammary Development1

GH peak response to GHRH-arginine: relationship to insulin resistance and other cardiovascular risk factors in a population of adults aged 50-90

Early mammary development: growth hormone and IGF-1

Primary therapy for acromegaly with somatostatin analogs and a discussion of novel peptide analogs

Suchergebnisse filtern